KUBOTA PHARMACEUTICAL HOLDINGS CO LTD (Form: 4, Received: 02/08/2017 14:26:19)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* SBI Holdings, Inc.	2. Issuer Name and Ticker or Trading Symbol KUBOTA PHARMACEUTICAL HOLDINGS CO LTD [ NONE ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle) IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI, MINATO-KU	3. Date of Earliest Transaction (MM/DD/YYYY) 1/12/2017
(Street) TOKYO, M0 106-6019	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person
(City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	1/12/2017		P		7,100	A	$63,447.32 ⁽¹⁾	8,259,556	I	By SBI Incubation Co., Ltd. ⁽²⁾
Common Stock	1/19/2017		P		100	A	$869.6 ⁽³⁾	8,259,656	I	By SBI Incubation Co., Ltd. ⁽²⁾
Common Stock	1/20/2017		P		12,900	A	$111,884.33 ⁽⁴⁾	8,272,556	I	By SBI Incubation Co., Ltd. ⁽²⁾
Common Stock	1/23/2017		P		17,200	A	$150,643.21 ⁽⁵⁾	8,289,756	I	By SBI Incubation Co., Ltd. ⁽²⁾
Common Stock								6,196,869	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:
(1)	The shares were purchased at a price of 7,310,400 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.
(2)	These shares are held directly by SBI Incubation Co., Ltd., which is an indirect wholly-owned subsidiary of SBI Holdings, Inc. SBI Holdings, Inc. may be deemed to be the indirect beneficial owner of these securities.
(3)	The shares were purchased at a price of 99,900 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.
(4)	The shares were purchased at a price of 12,884,600 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.
(5)	The shares were purchased at a price of 17,167,300 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
SBI Holdings, Inc. IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI MINATO-KU TOKYO, M0 106-6019		X

Signatures
/s/ Yoshitaka Kitao, Representative Director, President & CEO		2/8/2017
^**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.